Meet the jobs matchmaker filling roles at Sizewell C
Stuart Allsopp has met hundreds of local job seekers over the last year. As Jobs Service lead at Sizewell C, he's one of the team responsible for making sure that opportunities at the project are matched up with people in the local area.
'There is a massive appetite for jobs in this region, and people are coming out to our Sizewell C jobs fair in big numbers,' said Stuart. 'My role is all about trying to deliver those jobs to people, to connect them with the best opportunities for them. It's what I love doing.'
Sizewell C offers a once-in-a-generation opportunity for jobs and careers in this region. Of the 1,500 apprenticeships the project is creating, 540 will go to local people. At least a third of the 7,900 jobs on offer during the peak of construction will go to people in this region. And once constructed, the power station will employ 900 people in highly skilled, well-paid jobs.
'We've got to make sure people are aware of the thousands of opportunities on offer,' said Stuart. 'And that means going out and putting the opportunities in front of them.'
READ MORE: How Sizewell C is aiming to provide world-class wellbeing support
Sizewell C has so far run jobs fairs in Leiston, Lowestoft and Ipswich, with a second jobs fair in each town to come later in the year.
'We signed jobs pledges with Jack Abbott MP in Ipswich and Jess Asato MP in Lowestoft, so these jobs fairs are one way we're delivering on those pledges. And we've already seen so many good news stories coming out of these events – of local people linking up with new jobs, either directly on the project or with one of the businesses in our supply chain.
Engineering apprentices at Sizewell C (Image: Sizewell C) 'It's such a satisfying feeling when you can match up someone with a job – that's no small thing, that's about improving people's lives. And that is happening on an ever-increasing scale because of this project. It's amazing.'
As well as jobs fairs and local advertising, the Sizewell C Jobs Service has been a successful way of making people aware of all the opportunities available.
'We want to make it easy for people and the Jobs Service does that. People can sign up on our website to get notifications of the latest opportunities – and we put all our vacancies on the website too, both roles directly with us and with our supply chain partners. There are well over a hundred opportunities live on the website at any one time.'
READ MORE: How Sizewell C is bringing hydrogen buses to Suffolk
Last week, Sizewell C announced that it was taking transformative steps to develop the skilled workforce it needs to build the power station: it's set to build a new post-16 college for Leiston, in partnership with Suffolk New College, as well as an apprenticeship and trainee hub to support hundreds of Sizewell C apprentices, and a Centre of Excellence focused on developing skills in civils, mechanical, electrical, welding and more.
'It's going to be phenomenal,' said Stuart. 'The difference it will make to young people in the Leiston area is difficult to overestimate – having those facilities on their doorstep will mean hundreds of young people can get the training, the skills, and the career pathways they want, without having to do an hour and half trip to a college out of town.
The Jobs Service is a great way of keeping up to date with opportunities on the project (Image: Sizewell C) 'In the short term, that means an even bigger pool of local talent for me to match up with roles here at Sizewell C. In the longer term, it means we can develop the skills and retain those skills for Suffolk here well into the future – it's a legacy in the truest meaning of the word.'
READ MORE: How Sizewell C is restoring Suffolk's Sandlings landscape
The next jobs fair is in Ipswich in August, and Stuart is expecting hundreds more people to come along as jobs on the project continue to increase.
'We had over a thousand people on site at the start of the year and we expect double that by the end of the year. We've got over 60 apprentices already and we expect to double that by the end of the year too.
'There is the supply of jobs to meet the clear demand we're seeing across the region – and this will have a positive ripple effect across our local economies. It's a joy to be involved in.'
For more information, visit
This article is part of the EADT's Clean & Green campaign, which aims to promote our region as the biggest in the UK and Europe for all forms of renewable energy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
14 minutes ago
- Forbes
The World's Best Vodka- According To The 2025 International Wine And Spirit Competition
The vodkas that won Gold Outstanding medals at the 2025 IWSC. Sophia Lindenberger Vodka may be the most under appreciated spirt in the world. Yes, it routinely tops the charts in sales across the globe, but it's the gins, whiskeys, tequilas and rums of the world that hog all the headlines. That is due to vodka's misunderstood nature; most people think it is a neutral spirit or an invisible mixer. They couldn't be further from the truth. These days, there is a wide array of premium vodkas in the market that showcase subtle mouthfeel and flavor derived from their diverse base ingredients, such as rye's spice, wheat's creaminess, potato's richness, or sugar beet's sweetness. Nowhere is this more on display than in the recently announced Gold Outstanding medal winners from the 2025 International Wine and Spirits Competition (IWSC). For over half a century, the IWSC has been running alcoholic beverages (over 12,000 this year) through its rigorous blind judging panels to discern the world's best bottles. They just awarded 10 Gold Outstanding medals in the vodka category. To qualify, each medal winner had to score a minimum of 98 out of 100 points in judging. Each of the winners is in the running for the IWSC's Vodka Trophy that will be awarded in November. Here is a brief recap of each winner and the judge's notes. Witchmark Distillery's Single Origin English Vodka is crafted by a young whisky distiller in Norfolk, England. While none of their whiskies are ready for release yet, their vodka and gin are quickly garnering fans; one can only imagine what their aged whiskies will deliver when they are released. Distilled from local barley, it has a creamy, rounded profile, lending it exceptional smoothness and versatility. Witchmark's commitment to controlling the entire process from raw ingredient to finished spirit ensures a pure and clean expression. It's a compelling choice for those seeking an authentic, high-quality English spirit. Here is what the judges had to say: The rich and malty nose entrances, with cocoa-studded dough inviting curiosity. The palate reveals a delightful combination of mint and toffee apple. The finish is pleasantly warming, leaving a luscious, oily texture that lingers. From Iceland's Eimverk Distillery, Iceland's first whisky maker, comes Kría Single Grain Vodka, a truly unique spirit born from its pristine environment. This vodka is made from locally grown Kría barley, used to craft their whiskies, and benefits from the island's pure, naturally filtered spring water. It's a distinct offering that has not been released to the public yet, though their showing at the IWSC should soon change that. Here is what the judges had to say: A fragrant embrace of baked sesame pastry and sweet cream cheese greets the senses, leading to a sumptuous palate of toffee, baked apple, and anise, all wrapped in a silky texture. The finish reveals a rich tapestry of honey and grain, leaving a lasting impression. Adnams, a 150-year-old brewery and distillery in Southwold, England, has some serious credentials behind its Longshore Triple Malt Vodka. It has twice won the Vodka Trophy at the IWSC. Unlike typical vodkas, this is distilled from a distinctive blend of East Anglican barley, wheat, and oats, imparting a truly unique character. You'll find a notably creamy texture, with inviting notes of oat and butterscotch, alongside a natural sweetness from the malted grains. It's known for its remarkable smoothness and approachable complexity, proving that vodka can offer more than just neutrality. Here is what the judges had to say: Invitingly creamy with delicate floral notes. The palate offers a luscious berry mouthfeel intertwined with strawberry, raisins, and a touch of maple syrup. Soft, peppery finish reminiscent of apple pie and a whisper of vanilla marzipan. Delightful. Belvedere Vodka helped launch the premium vodka category in the late 20th century with its distinctive Polish offerings. Their super-premium 10 Vodka is the pinnacle product for the brand. Crafted from a single, prized harvest of Dankowskie Diamond Rye, the "10" signifies the ten stages of vodka creation and the year the distillery was founded 1910. This meticulous process yields an exceptionally smooth and crisp vodka that is far from neutral. First released in 2023, it's designed for those who appreciate ultimate purity and a complex, highly refined sipping experience, setting a new benchmark for luxury vodka. Here is what the judges had to say: Aromas of rich caramel and a whisper of spice. Silky textured palate with a robust peppery character, complemented by creamy vanilla, sourdough notes and delicate florals. Warm, zesty finish that is both silky and long-lasting. Well-balanced with a fantastic profile. Laplandia, a company owned by a family of entrepreneurs, was founded in 2009 to craft exceptional spirits in the Finnish northern wilderness region of Lapland. By using the pure artesian waters of the area combined with wheat from family-owned farms, they can produce strikingly clean vodkas. Bilberry Vodka is a flavored vodka infused with bilberry, a wild blueberry native to Arctic regions, lending a unique sweet-tart berry profile that stands apart from common blueberry flavors. It's a compelling choice for those seeking an authentic and vibrant fruit-flavored vodka experience. Here is what the judges had to say: Vibrant fruity nose underscored by creamy undertones. The palate reveals a delightful interplay of wild blueberries and sour cherries, harmoniously balanced with sweet vanilla and luscious berry jam. Refreshing, juicy brightness to finish, accented by a hint of bitterness. Outstanding. For their second award-winning vodka, Laplandia used another local ingredient to craft a great sip. Its Cloudberry Vodka is infused with the rare and prized cloudberry, a golden-orange fruit found in Arctic climates, known for its unique sweet, subtly tart, and intensely aromatic taste. Like other Laplandia expressions, it benefits from a premium grain spirit base and pristine Arctic spring water. It's a distinctive choice for those seeking a unique, natural berry flavor that captures the wild essence of the Nordic North. Here is what the judges had to say: A delightful burst of orange marmalade and caramel layered with hints of peach and apricot. The palate reveals a captivating sweetness complemented by clove and honey, while a subtle touch of white pepper and dry, root notes linger beautifully. Hawkridge Distillers, a seven-year-old distiller based in England's Berkshire County, collaborated with London's acclaimed Sexy Fish restaurant to produce this distinctive vodka. Crafted likely as a house pour or signature spirit for the high-end establishment, it emphasizes exceptional smoothness and purity. While specific botanical details are often private for such collaborations, the focus is on a refined, neutral, or subtly nuanced profile that excels in sophisticated cocktail creations. It's a vodka that should highlight its three founders, all distillers, skill in crafting memorable bottles. Here is what the judges had to say: The aroma presents a delicate blend of floral and fruity notes, beautifully enhanced by a touch of peppery spice and sweet icing sugar. The profoundly deep palate resonates with creamy hints of smooth vanilla and lusciously crisp citrus. If you have never heard of Eckerts Wacholder Brennerei GmbH, don't feel bad; it's doubtful many people have. Located in the Saarland region of Germany, adjacent to Luxembourg and France, it is a 125-year-old distiller with a minimal footprint. They make a wide array of small-batch whiskeys that are sold in the region. Their vodka is an experimental product that they only serve onsite. They must be doing something right since they took home two GO medals at the IWSC. Here is what the judges had to say: Light minerality and creamy vanilla on the nose. The palate bursts with a harmonious blend of woodiness and grassiness, enriched by caramel undertones, hints of stone fruit, and vibrant orange marmalade. A luscious mouthfeel leads to a clean, refreshing finish. This is another winner from Germany's Eckerts Wacholder Brennerei GmbH. As stated before, there is not much known about this distillery; it is distinctly local. Korol Black Vodka is another experimental product available only onsite. One thing is for certain, though. If you find yourself visiting the Saarland region of Germany, you should search for this distillery. With 125 years of experience, they seem to be making some great spirits. Here is what the judges had to say: A delightful bouquet of sweet wheat leads to a palate revealing delightful notes of bittersweet cereal wrapped in creamy icing sugar. Boasts a rounded, uplifting finish, where warm spice lingers beautifully on the tongue. Absolut Hunni, a brand-new product from Sweden's iconic Absolut Vodka, is currently only available in England, but hopefully, that will change soon. A naturally flavored vodka, it is crafted using Swedish winter wheat and natural honey flavorings to deliver a sweet, smooth sip. Like all Absolut vodkas, it benefits from a continuous distillation process, ensuring consistent quality and purity without added sugars. It is a super-premium flavored vodka that could change the conversations around the flavored vodka category as distillers look to deliver more natural products to consumers. Here is what the judges had to say: Delightful aromas of fresh Acacia honey, complemented by distinctive floral notes. On the palate, sweet heather honey shines through, intermingled with a lingering peppery warmth and gorgeous hints of fresh honeycomb. Follow here for the most up to date information about the ever changing beer, wine, and spirits industry.
Medscape
34 minutes ago
- Medscape
Thousands Missing Out on Life-Saving Heart Treatments
MANCHESTER — Thousands of people in the United Kingdom with advanced heart failure are not being referred for potentially life-saving treatments, a leading heart transplantation expert said at the British Cardiovascular Society Annual Conference 2025. Owais Dar Owais Dar, a consultant cardiologist at Harefield Hospital, Guy's and St Thomas' NHS Foundation Trust, London, described a 'systemic failure' in delivering transplants and left ventricular assist devices (LVADs) to eligible patients in the UK. This failure was leading to a 'deadly delay' in care, he said. Presenting data from a National Advanced Heart Failure Audit, Dar estimated that 10,000 adults under 65 who could be eligible for a heart transplant or LVAD therapy had not been referred to specialist services. Furthermore, 130,000 adults with advanced heart failure were living with palliative care needs. 'If this was a cancer, we would be furious about this,' said Dar, who is also an honorary senior lecturer at King's College London. 'We've got young people here who are not accessing [these therapies].' Dar noted wide variation in referral patterns. Even in regions with the highest rates of referral, the numbers fell short of what was needed. 'Generally, within the UK and Ireland, we're just not thinking about transplant or LVAD therapy as even an option,' he said. Specialist Services at Risk of Being Overwhelmed Geraint Jenkins, a consultant cardiologist at Morriston Hospital in Swansea, Wales, told Medscape News UK : 'The majority of the patients these days — because medical therapy is so good — get better.' He observed that half of patients with an ejection fraction under 30% regain nearly normal heart function within a year, 'and they don't get anywhere near a transplant centre'. Jenkins warned that current referral criteria were 'lax' and, if followed, could overwhelm specialist services. 'We've got thousands of patients with ICDs [implantable cardioverter defibrillators], and the number of patients having ICD shocks every month is quite substantial,' he said. 'If they all went to Harefield for assessment, that would swamp their services.' Jenkins stressed the importance of identifying the right patients at the right time, which meant finding the 'sweet spot' for patient referral. 'That's what we're not doing well,' he said. LVADs Offer Alternative Solution Separately, Dar told Medscape News UK that while there may not be enough hearts to match presumed demand, modern LVADs were 'almost as good' an alternative. LVADs are mechanical pumps that support circulation in patients with severely weakened hearts. They can be used for long-term support or as a bridge to transplant. Theoretically there were 'unlimited amounts of LVADs', Dar said. As these were 'off-the shelf' items, the waiting time should be shorter than for an appropriate organ donation. Many patients already had access to other advanced treatments like ICDs and cardiac resynchronisation therapies (CRTs), he added. 'The only option they have is an operation that can allow them to live another 8 years.' He emphasised the benefits for younger patients: 'That's giving them back quality life, where they can work again, exercise and do things again – going from being bed bound and possibly dying within a year.' High Mortality in Advanced Heart Failure Dar said advanced heart failure carries significant mortality risk. One-year mortality is around 40% using European Society of Cardiology (ESC) criteria, and 20% with American Heart Association benchmarks. Based on US data, around 14% of a population of around 60,000 met ESC criteria for advanced heart failure, with 5% 'within transplantable age' from 18 to 65, said Dar. Extrapolated to the UK with a total population of 68 million, one million would have a diagnosis of heart failure, 140,000 would have advanced disease, 50,000 would be under 65, and 10,000 eligible for transplantation or LVAD therapy. A 'feeling that we were not getting enough referrals' had led Dar and other transplant physicians across the UK and Ireland to form a working group to look into the issue. The aim was to create a heatmap of referrals that had been made to heart transplant and LVAD centres and assess inequality and equity of care. Audit Exposes Regional Inequalities The working group audited four months of referral data, including 416 patients with a median age of 52. Most were men (67%) and White (73%), with a non-ischaemic cause of heart failure (55%). In 44% of outpatient referrals and 17% of inpatient referrals, patients were considered 'too well' for transplant or LVAD. Respectively, 29% and 39% had contraindications to either option, with 19% and 31% progressing towards a transplant or device fitting. High body mass index was a key exclusion factor, alongside liver or kidney failure, diabetes-related organ damage, or smoking. The audit found significant regional variation – a 'postcode lottery' in access. 'There are large areas, particularly in Wales and the Northeast of England, that are simply not referring patients with advanced heart failure – for transplant or LVAD therapy,' Dar noted. Even areas around specialist transplant centres were not referring patients, he added. Calls for a National Referral Pathway 'It's affirmed what we suspected,' Dar told Medscape News UK . 'So, I think the idea now is to speak to NHS England and colleagues to try and address this inequality and raise awareness of it to see how we can improve things.' One approach, he suggested, might be to create a national pathway that sets out how quickly someone with suspected advanced heart failure was seen by a specialist team. Jenkins observed that travelling to specialist centres could be a problem for many patients living in more rural areas who could face long journeys. He suggested that specialists could perhaps hold monthly clinics withing existing heart failure centres. Whatever the reason for the lack of referrals, Dar said it was clear that more needed to be done: 'We're failing these patients. Speak to your local transplant centres about your patients and just have that conversation early on.' D ar and Jenkins declared no relevant financial relationships
Forbes
35 minutes ago
- Forbes
The ‘Doctor Who' Regeneration Controversy, Explained
Billie Piper as the 16th Doctor in 'Doctor Who' 'The Reality War,' the finale of the 15th season of Doctor Who, saw Ncuti Gatwa exit the role of the Doctor, regenerating into Billie Piper, who previously appeared in the series as the Doctor's companion. Fans of the show were shocked at the reveal, as recasting a former companion as the Doctor was a first for the long-running sci-fi series. The Doctor has been played by a total of 16 different actors across the show's 60-year history, with each new actor introduced via 'regeneration.' Doctor Who is an interesting example of a sci-fi story offering viewers an in-universe explanation for the inevitable recasting that occurs during a multi-decade series. The Doctor is a member of an ancient alien race known as the Time Lords, who have the ability to regenerate into a fresh body when fatally wounded, imbuing them with a new personality and appearance. Canonically, Time Lords are limited to 12 regenerations, but of course, the Doctor was granted an exception, so that the series could continue. The ability to regenerate can result in a Time Lord changing race and sex, and the Doctor's recent regenerations have introduced more diversity to the series, but the show's latest regeneration proved controversial with fans. The backlash wasn't some tedious culture war bickering, but a debate over canon, nostalgia and the future of the show. 'The Reality War' sees Ncuti Gatwa's Doctor regenerate into Billie Piper, who first appeared in the series as Rose Tyler. Rose was the Doctor's companion between 2005 and 2013, during the eras of Christopher Eccleston and David Tennant, who both played the Time Lord. Many fans viewed the recasting of a previous companion as a desperate move motivated by nostalgia. One commentator even explained the casting through the lens of Spider-Man, so outsiders could understand the controversy. The discourse sparked a discussion about what kind of audience is still watching Doctor Who today, with some asserting that children are no longer the main audience of the series. Other commentators were disappointed to see Gatwa's time as the Doctor end so abruptly. Gatwa's Doctor was unusually short-lived, lasting a mere 18 months, and the actor never got to see his Doctor face off against the series' most iconic villains. Some viewed the modern Doctor Who regenerations as too frequent, with actors leaving the show before they could truly leave their mark on the role. Many comparisons were made to the MCU recasting Robert Downey Jr. as Doctor Doom, a movie which was widely viewed as a gimmick among Marvel fans. Some fans even suspected that there was more to the story, and that Piper's casting was a red herring, noting that Piper was not officially introduced as the Doctor in the show's credits. 'Just how and why she is back remains to be seen,' the BBC said in a suspiciously vague statement after the finale aired. 'It's an honour and a hoot to welcome her back to the TARDIS, but quite how and why and who is a story yet to be told,' showrunner Russell T. Davies said. Despite the controversy, Piper sounded optimistic about her new role, saying that the opportunity to "step back on that TARDIS one more time was just something I couldn't refuse.'
